| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 10024-58-5 | Didecanoyltriethylene glycol ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 16474-36-5 | Decaneperoxoic acid tert-butyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 14727-56-1 | Decalin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | | CPX |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 73772-44-8 | Capramidopropylamine oxide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 870070-55-6 | Tozadenant |
≥98% | | 询价 |
| 7 | 606-58-6 | Toyocamycin(Vengicide) |
≥98% | | 询价 |
| 8 | 851606-62-7 | Totrombopag choline |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 376592-42-6 | Totrombopag |
≥98% | | 询价 |
| 10 | 511-15-9 | Totarol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 127-65-1 | Tosylchloramide sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 1345337-28-1 | Tos-PEG9-t-butyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 1530777-90-2 | Tos-PEG7-CH2CO2tBu |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 850090-10-7 | Tos-PEG6-t-Butyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 167626-17-7 | OPC-28326 HCl hydrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 167621-24-1 | OPC 28326 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 1949793-62-7 | Tos-PEG6-CH2CO2tBu |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 581065-94-3 | Tos-PEG5-t-butyl ester |
≥98% | | 询价 |
| 19 | 169751-73-9 | Tos-PEG5-CH2CO2tBu |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 2028284-73-1 | Tos-PEG5-CH2CO2H |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 217817-01-1 | Tos-PEG4-t-butyl ester |
≥98% | | 询价 |
| 22 | 1239588-09-0 | Tos-PEG4-methyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 1581248-63-6 | Tos-PEG4-CH2CO2H |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 1323077-89-9 | Enzaplatovir |
≥98% | | 询价 |
| 25 | 36702-84-8 | Novocebrin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 191034-25-0 | L-168,049 |
≥98% | | 询价 |
| 27 | 128253-31-6 | Veliflapon |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 72301-79-2 | Enviroxime |
≥98% | | 询价 |
| 29 | 80883-55-2 | Enviradene |
≥98% | | 询价 |
| 30 | 125-65-5 | Pleuromulin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 501121-34-2 | ent-Atorvastatin |
≥98% | | 询价 |
| 32 | 501921-61-5 | Entasobulin |
≥98% | | 询价 |
| 33 | 1631-64-7 | ENT-27086 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 3954-73-2 | ENT 25788 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 1713-54-8 | ENT 25642 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 115-92-4 | ENT 25641 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 1884461-72-6 | Ensifentrine |
≥98% | | 询价 |
| 38 | 179324-22-2 | MG-262 |
≥98% | | 询价 |
| 39 | 209969-60-8 | Ensaculin HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 167256-08-8 | Enrasentan |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 73121-56-9 | Enprostil |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 433311-07-0 | MI-1 |
| | 询价 |
| 43 | 10087-89-5 | Enpromate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 131-57-7 | Oxybenzone |
| 5g | 询价 |
| 45 | 1071992-99-8 | AT-406 |
| 10mg, 50mg | 询价 |
| 46 | 238410-11-2 | Enoxastrobin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 2238-90-6 | Psychosine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 127035-60-3 | Enofelast |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 55726-47-1 | Enocitabine |
≥98% | | 询价 |
| 50 | 101910-65-0 | EP 157 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 1699750-95-2 | EOAI3402143 Tosylate |
≥98% | | 询价 |
| 52 | 344457-87-0 | EO-1606 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 23581-62-6 | EO-122 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 288847-34-7 | OXi-4503 sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 798543-50-7 | KBH-A42 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 1453117-42-4 | Tos-PEG4-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 850090-13-0 | Tos-PEG3-t-butyl ester |
≥98% | | 询价 |
| 58 | 882518-89-0 | Tos-PEG3-CH2CO2tBu |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 1807537-35-4 | Tos-PEG3-CH2CO2H |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 1309666-78-1 | Tos-PEG2-t-butyl ester |
≥98% | | 询价 |
m.cnreagent.com